Pharmaceutical companies stand ready to be tested in a world where a drug's success is more closely tied to its performance.
The challenges mount with competition from generics and growing pressure to reduce costs.
Now, insurers and integrated providers are driven by models that reward health outcomes and cost savings.
For success, drug makers are exploring real-world evidence, new payment models, and the right partnerships.


Evaluation of Enzyme Inhibitors in Drug DiscoveryEvaluation of Enzyme Inhibitors in Drug Discovery
A Guide for Medicinal Chemists and Pharmacologists, by Copeland, Robert A.

With enzymes being the most valued and common of drug targets, an understanding of their interactions with inhibitors is critical to successful drug discovery.

Now in a second edition, this proven work clearly explains the biochemical data and experimental details underlying the science, arming medicinal chemists and pharmacologists with the tools they need to master the art of applied enzymology for drug discovery.

bio-based economyBio Base Europe is the Europe's first open innovation and education centre for the biobased economy.

Flanders and The Netherlands have joined forces to build state-of-the-art research and training facilities to speed up the economic growth, innovation capacity, and sustainable development of our society.

Bio Base Europe consists of the Bio Base Europe Pilot Plant and the Bio Base Europe Training Centre.

The Bio Base Europe Pilot Plant is a flexible and multi-purpose pilot plant for bio-based products and processes.

peroxicatsPeroxicats [peroxidases as biocatalysts]. Novel and more robust fungal peroxidases as industrial biocatalysts.

[This article is based on the presentation of the Peroxicats FP7 project. Grant agreement nº: KBBE-2010-4-265397. Total budget: 4.3 million €; EC-funding: 3 million €]

Enzymes catalyzing redox reactions (oxidoreductases) represent an environmentally friendly alternative to harsh chemicals in industrial processes that include oxidative transformations for production of chemicals and other value-added products with large markets in developed and emerging economies.

Fungi and other microorganisms provide the wider and more easily exploitable source for oxidative enzymes.

However, the penetration of microbial oxidoreductases in the chemical markets is still low despite the recent discovery of very promising enzymes.

what do you think?Knowing what the client wants is the key factor to success in any type of business. News media, government agencies and political candidates need to know what the public thinks. Associations need to know what their members want. Large companies need to measure the attitudes of their employees. The best way to find this information is to conduct a survey.

Conducting surveys can be done very simply, or it can be very complicated, depending on how much you want to ask on the survey and the number of people to whom it is administered. Here some information for small/medium scale surveys. These are certainly not a strict prescription and they should be clearly adapted to your needs, especially if you go to larger/multiple target groups.

This article provides an overview of the key points related to surveys. It is divided into 12 web pages with a table of content...